Musolino A; Michiara M; Bella MA; Naldi N; Zanelli P; Bortesi B; Capelletti M; Soldani L; Camisa R; Martella E; Franciosi V; Savi M; Neri TM; Ardizzoni A; Cascinu S, Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study, «TUMORI», 2005, 91, pp. 505 - 512 [replica/breve intervento]
Trombino S; Neri M; Puntoni R; Angelini C; Loprevite M; Cesario A; Granone P; Imperatori A; Dominioni L; Ardizzoni A; Filiberti R; Russo P, Mutations in K-ras codon 12 detected in plasma DNA are not an indicator of disease in patients with non-small cell lung cancer, «CLINICAL CHEMISTRY», 2005, 51, pp. 1313 - 1314 [replica/breve intervento]
Tiseo M; Boni L; Ardizzoni A, Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: Does cisplatin versus carboplatin make a difference?, «JOURNAL OF CLINICAL ONCOLOGY», 2005, 23, pp. 6276 - 6277 [replica/breve intervento]
Ardizzoni A; Favaretto A; Boni L; Baldini E; Castiglioni F; Antonelli P; Pari F; Tibaldi C; Altieri AM; Barbera S; Cacciani G; Raimondi M; Tixi L; Stefani M; Monfardini S; Antilli A; Rosso R; Paccagnella A, Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: Results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis - A Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study, «JOURNAL OF CLINICAL ONCOLOGY», 2005, 23, pp. 569 - 575 [replica/breve intervento]
Filiberti R; Marroni P; Neri M; Ardizzoni A; Betta PG; Cafferata MA; Canessa PA; Puntoni R; Ivaldi GP; Paganuzzi M, Serum PDGF-AB in pleural mesothelioma, «TUMOR BIOLOGY», 2005, 26, pp. 221 - 226 [replica/breve intervento]
Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C, Treatment of advanced non-small-cell lung cancer in the elderly: Results of an international expert panel, «JOURNAL OF CLINICAL ONCOLOGY», 2005, 23, pp. 3125 - 3137 [replica/breve intervento]
Cafferata MA; Chiaramondia M; Monetti F; Ardizzoni A, Complete spontaneous remission of non-small-cell lung cancer: a case report, «LUNG CANCER», 2004, 45, pp. 263 - 266 [replica/breve intervento]
Giaccone G; Smit EF; de Jonge M; Dansin E; Briasoulis E; Ardizzoni A; Douillard JY; Spaeth D; Lacombe D; Baron B; Bachmann P; Fumoleau P, Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer: a phase II trial of the EORTC-New Drug Development Group, «EUROPEAN JOURNAL OF CANCER», 2004, 40, pp. 667 - 672 [replica/breve intervento]
Loprevite M; Favoni RE; De Cupis A; Scolaro T; Semino C; Mazzanti P; Ardizzoni A, In vitro study of farnesyltransferase inhibitor SCH 66336, in combination with chemotherapy and radiation, in non-small cell lung cancer cell lines, «ONCOLOGY REPORTS», 2004, 11, pp. 407 - 414 [replica/breve intervento]
Monetti F; Casanova S; Grasso A; Cafferata MA; Ardizzoni A; Neumaier CE, Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases, «LUNG CANCER», 2004, 43, pp. 71 - 74 [replica/breve intervento]
Merisio C; Bozzetti C; Bortesi B; Capelletti M; Bella MA; Zanelli P; Neri TM; Melpignano M; Cascinu S; Ardizzoni A, LOSS OF HETEROZYGOSITY (LOH) IN OVARIAN CANCER, «ANNALS OF ONCOLOGY», 2004, 15, pp. 45 - 45 [abstract]
Sgargi P; Michiara M; Bella MA; Musolino A; Naldi N; Zanelli P; Cappelletti M; Bortesi B; Ardizzoni A; De Lisi V, MULTIPLE COLORECTAL-ENDOMETRIAL (CEC) AND YOUNG AGE ONSET ENDOMETRIAL CANCER (EC): ARE THEY A FAMILY MARKER FOR HEREDITARY NON-POLYPOSIS COLORECTAL CARCINOMA SYNDROME (HNPCC)?, «ANNALS OF ONCOLOGY», 2004, 15, pp. 64 - 64 [abstract]
Ardizzoni A; Tiseo M, Predictors of clinical response of non-small cell cancer to gefitinib, «JAMA», 2004, 291, pp. 1563 - 1563 [replica/breve intervento]
Gatzemeier U; Groth G; Butts C; Van Zandwijk N; Shepherd F; Ardizzoni A; Barton C; Ghahramani P; Hirsh V, Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer, «ANNALS OF ONCOLOGY», 2004, 15, pp. 19 - 27 [replica/breve intervento]
Ardizzoni A; Tiseo M, Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC), «JOURNAL OF CHEMOTHERAPY», 2004, 16, pp. 104 - 107 [replica/breve intervento]
